Good day, and welcome to the Chicago Atlantic Real Estate Finance, Inc. Second Quarter 2025 Earnings Call. Please note this event is being recorded. I would now like to hand the call to Harry M. Sullivan of Investor Relations. Please go ahead.

Thank you. Good morning. Welcome to the Chicago Atlantic Real Estate Finance conference call to review the company's results. On the call today will be Peter Sack, Co-Chief Executive Officer; David Kite, Chief Operating Officer; and Phil Silverman, Chief Financial Officer. Our results were released this morning in our earnings press release, which can be found on the Investor Relations section of our website, along with our supplemental filed with the SEC. A live audio webcast of this call is being made available today. For those who listen to the replay of this webcast, we remind you that the remarks made herein are as of today and will not be updated subsequent to this call. During this call, certain comments and statements we make may be deemed forward-looking statements within the meaning prescribed by the securities laws, including statements related to the future performance of our portfolio, our pipeline of potential loans and other investments, future dividends and financing activities. All forward-looking statements represent Chicago Atlantic's judgment as of the date of this conference call and are subject to risks and uncertainties that can cause actual results to differ materially from our current expectations. Investors are urged to carefully review various disclosures made by the company, including the risk and other information disclosed in the company's filings with the SEC. We also will discuss certain non-GAAP measures, including, but not limited to, distributable earnings. Definitions of these non-GAAP measures and reconciliations to the most comparable GAAP measures are included in our filings with the SEC. I'll now turn the call over to Peter Sack. Please go ahead.

Thank you, Tripp. Good morning, everyone. While the cannabis equity markets have vacillated on the headlines surrounding the DEA and rescheduling and other capital providers have been inconsistent in their commitments to the industry, we've maintained our steady-as-it-goes approach. We're deploying capital with consumer and product-focused operators in limited license jurisdictions at low leverage profiles to support fundamentally sound growth initiatives. More importantly, we're staying disciplined and patient by making decisions based on credit and our ability to protect principal and achieve strong risk-adjusted returns. The cannabis pipeline across the Chicago Atlantic platform has increased from $462 million a quarter ago to nearly $650 million today. We have a number of signed term sheets within this pipeline that should offset the early Q3 payoffs and keep us on track for net portfolio growth for the year. Upcoming maturities in the market, M&A activity related to operational and balance sheet restructurings, and a growing number of ESOP sale transactions drive recent pipeline growth. With our long history in the industry and over $2.2 billion of capital deployed in the cannabis industry alone, we continue to have the most robust platform to meet the growth of the industry. We enhanced our ability to support that growth with the recent extension of our credit facility with no change to the economic terms from June 30, 2026 to June 30, 2028. Our overriding goal for our shareholders is to create a differentiated and low-levered risk-return profile that is insulated from cannabis equity volatility and outperforms our industry-agnostic mortgage REIT peers. While there has been some near-term divergence in the financial services industry due to uncertainty around tariffs and the direction of interest rate policy, we're confident that we will outperform long-term and deliver strong returns to our shareholders. David, why don't you take up from here?

Thank you, Peter. As of June 30, our loan portfolio principal totaled $421.9 million across 30 portfolio companies with a weighted average yield-to-maturity of 16.8% compared with 16.9% for the first quarter. Gross originations during the quarter were $16.5 million of principal fundings, of which $10 million was an upsize and refinance of loan #7 and $6.5 million was funded to existing borrowers on delayed draw term loan facilities. These were partially offset by scheduled principal amortization payments received of $3.1 million. As of June 30, 2025, the percentage of our portfolio comprised of fixed-rate loans and floating-rate loans was 40.7% and 59.3%, respectively. Our floating rate loans are generally benchmarked against the prime rate. When factoring for prime rate floors, 70.9% of the portfolio would be unaffected by prime rate declines up to 50 basis points, and 91.2% of the portfolio would be unaffected by prime rate declines up to 75 basis points. Meanwhile, our floating rate loans are not exposed to interest rate caps. We believe the portfolio remains well-positioned to limit the impact of interest rate declines should the Federal Reserve decide to adjust Fed funds target later in the year. Total leverage equaled 39% of book equity at June 30 compared to 28% as of March 31. Our debt service coverage ratio on a consolidated basis for the quarter was approximately 4.27:1 compared with the requirement of 1.35:1. As of June 30, we had $71.2 million outstanding on our senior secured revolving credit facility and $50 million outstanding on our unsecured term loan. As of today, we have approximately $97.6 million available on the senior credit facility with total liquidity net of estimated liabilities of approximately $94 million. The increase in availability under our leverage facility since quarter end results primarily from the application of approximately $56.8 million of proceeds from loan prepayments from 6 credit facilities subsequent to quarter end. To date in the third quarter, we recognized make-whole and prepayment fees on these prepayments of approximately $1 million. I'll now turn it over to Phil.

Thanks, David. Our net interest income of $14.4 million for the second quarter represented a 10.6% increase from $13 million during the first quarter of 2025. The increase was primarily attributable to nonrecurring prepayment, make-whole, exit and structuring fees, which amounted to approximately $1.5 million for Q2 2025 compared with $0.4 million in Q1, as well as incremental gross interest income earned on our $16.5 million of new deployments. Total interest expense, including noncash amortization of financing costs for the second quarter was consistent with Q1 at approximately $2.1 million. The weighted average borrowings on our Revolving Loan remained relatively consistent at $42.3 million compared to $41.6 million during the first quarter. As David noted, the company has approximately $98 million available on our Revolving Loan. Our CECL reserve on our loans held for investment as of June 30, 2025, was approximately $4.4 million compared with $3.3 million as of March 31. During the second quarter, we placed loan #6 on nonaccrual status, which partially contributed to the sequential increase in the reserve, and this loan is included in risk rating 4 as of June 30. On a relative size basis, our reserve for expected credit losses represents approximately 1.1% of outstanding principal of our loan held for investment compared to 0.8% as of March 31. On a weighted average basis, our portfolio maintains strong real estate coverage of 1.2x. Our loans are secured by various forms of other collateral in addition to real estate, including UCC-1 all asset liens on our borrower credit parties. These other collateral types contribute to overall credit quality and lower loan-to-value ratios. Our portfolio has a loan-to-enterprise value ratio on a weighted average basis of 43.2% as of June 30, calculated as senior indebtedness of the borrower divided by the total fair value of total collateral to refinance. Distributable earnings per weighted average share on a basic and fully diluted basis were approximately $0.52 and $0.51 for the second quarter, an increase from $0.47 and $0.46 during the first quarter of this year. In July, we distributed the first quarter dividend of $0.47 per common share declared by our Board in June 2025. During the second quarter, approximately 181,000 restricted stock awards previously granted under our employee incentive plan vested to common stock and accrued dividends since their respective grant dates of approximately $0.6 million, which were paid in June 2025. Our book value per common share outstanding was $14.71 as of June 30, and there were approximately 21.5 million common shares outstanding on a fully diluted basis as of such date. We continue to expect to maintain a dividend payout ratio based on our basic distributable earnings per share of 90% to 100% for the 2025 tax year. If our taxable income requires additional distributions in excess of the regular quarterly dividend to meet our taxable income requirements, we expect to meet that requirement with a special dividend in the fourth quarter. Operator, we're now ready to take questions.

And our first question will come from Aaron Grey of Alliance Global Partners.

So first question for me. Pipeline went up nicely Q-over-Q. Just want to get some color in terms of what you're seeing in the pipeline. I understand it can be for the whole Chicago Atlantic platform. But was it more a function of operators realizing one of the limited options out there for capital? I just want to make sure there's no change in criteria qualifying for it to enter the pipeline or maybe just a function of larger potential opportunities that came in there. So any color that maybe drove some of the sequential increase in that pipeline?

Thanks, Aaron. Pipeline growth is driven by increased activity in the market of M&A, largely M&A, whether that's operational reorganization, ESOP transactions, and to a certain extent, refinancings of existing debt.

Great. Peter, second question for me, you mentioned some increased liquidity from some prepayments that happened subsequent to the quarter. Just kind of more broadly speaking, how do you view prepayments occurring for the remainder of the portfolio, maybe just sticking it out through the remainder of the year? Do you feel like there's a large number of loans where that could occur further? Do you feel like that's more limited in nature? Just want to get more color in terms of how you're seeing the potential for prepayments and then also how you're seeing the yields for those potential loans that are being prepaid and how you can then deploy that out into new loans?

Sometimes it's difficult to predict prepayments, which can be both beneficial and challenging. They indicate the success and quality of the portfolio, but also represent capital that needs to be reinvested in new opportunities. The prepayments that happened early in the third quarter were notably significant and exceeded my expectations for the rest of the year. However, predicting them remains a challenge. On the bright side, they don't come at a bad time considering the opportunities we currently have in our pipeline.

Our next question will come from Pablo Zuanic of Zuanic Associates.

Peter, can you just give an update on New York in terms of the relationship there with the agency, how the program is going? How many stores have you funded? What color can you share with us in that regard?

Yes. Relationship with the New York Social Equity Fund and the Dormitory Authority of New York is strong. We have a lot of faith in the program. They've built close to 23 dispensaries that are operating relatively successfully. We're really proud of what they've accomplished for those entrepreneurs. Those entrepreneurs that have been able to get their dispensaries open and are operating well. There's been a large amount of news around that market with regulations changing and controversy around how dispensaries were cited. But I'm confident that the governor's office and the legislature will find a solution and work their way through because it's in everyone's interest to do so. I think the New York market as a whole has been developing quite well in 2025. The wholesale market is developing, product quality and diversity have improved significantly, and the ecosystem of dispensary operators has become nicely developed. That's important for the ability of the legal market to compete with the illegal market. We've always said that there are three important prongs of a healthy legal operating market. You need access to dispensaries ideally within minutes of a 15-minute walk from your front door. You need high-quality, reliable product grown indoors year-round. And you need pricing that's competitive, including taxes, with potential legal competitors, and New York is getting that.

That's good. Looking at the bigger picture, many companies have upcoming maturities in the next 12 to 18 months. Can you discuss the overall landscape? It seems that some companies are taking a wait-and-see approach, anticipating federal reforms or positive developments at the state level. How is the demand side currently shaping up? Additionally, there appears to be increased competition, with some of your peers or competitors in different asset classes being more aggressive in their terms and financing. Could you elaborate on both the demand and supply aspects of the market right now?

Among the large-cap public operators are strong participants in the market, and we've participated and deployed capital into that segment of the market selectively. But that part of the market has never been our primary focus. Our primary focus tends to be operators that are 1 or 2 levels smaller, successful strong private multistate operators and single-state operators. We do find that among some of the larger public operators, ones that are large enough to have access to, for instance, the bond market, they do bring in a slightly different profile of lenders at times. But we don't really view them as competition; we view them as a different class of competition simply because that's a segment of the market that we don't focus on. I think the wait-and-see approach makes sense given cost of capital options. A lot of the bond maturities and debt maturities that are coming up in 2026 were priced at a time when overall interest rates were a lot lower and cannabis interest rates and cannabis access to capital was lower. So in that context, I think the wait-and-see approach makes a lot of sense.

And one last one, and only if you can talk about this, but when I think about Chicago Atlantic, I think about the group on the private side, I think about the BDC, right? That's listed. And I think about you guys. And I'm trying to understand with the BDC involved right now, the group as a whole has more tools in approaching the clients, the demand side. Can you talk about how that's helping you working out right now, again, in terms of what you can share?

Yes, absolutely. Having multiple funding sources allows us to be a stronger, more competitive and more flexible partner to our clients, to our borrowers. That’s important because the lifeline of private credit and debt financing underscores the quality of our portfolio ultimately stems from the quality of our pipeline, and the broader that we can make that pipeline, the largest number of opportunities that we can generate creates greater selection and ultimately leads to better quality. This is why we think that there's extreme value to being part of a broader platform that can take advantage of sourcing capabilities and underwriting capabilities that ultimately lead to a higher quality, more diversified portfolio in each of the vehicles that we manage.

This concludes our question-and-answer session. The conference has now also concluded. Thank you for attending today's presentation, and you may now disconnect.